Renee Lentini - Net Worth and Insider Trading

Renee Lentini Net Worth

The estimated net worth of Renee Lentini is at least $459,799 dollars as of 2024-05-26. Renee Lentini is the VP & PRIN ACCTG OFFICER of Immunogen Inc and owns about 14,723 shares of Immunogen Inc (IMGN) stock worth over $459,799. Details can be seen in Renee Lentini's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Renee Lentini has not made any transactions after 2024-02-05 and currently still holds the listed stock(s).

Transaction Summary of Renee Lentini

To

Renee Lentini Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Renee Lentini owns 1 companies in total, including Immunogen Inc (IMGN) .

Click here to see the complete history of Renee Lentini’s form 4 insider trades.

Insider Ownership Summary of Renee Lentini

Ticker Comapny Transaction Date Type of Owner
IMGN Immunogen Inc 2024-02-05 V.P.-Fin. & Prin. Acctg. Off.

Renee Lentini Latest Holdings Summary

Renee Lentini currently owns a total of 1 stock. Renee Lentini owns 14,723 shares of Immunogen Inc (IMGN) as of February 5, 2024, with a value of $459,799.

Latest Holdings of Renee Lentini

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMGN Immunogen Inc 2024-02-05 14,723 31.23 459,799

Holding Weightings of Renee Lentini


Renee Lentini Form 4 Trading Tracker

According to the SEC Form 4 filings, Renee Lentini has made a total of 4 transactions in Immunogen Inc (IMGN) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Immunogen Inc is the sale of 2,631 shares on February 5, 2024, which brought Renee Lentini around $77,088.

Insider Trading History of Renee Lentini

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Renee Lentini Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Renee Lentini Ownership Network

Ownership Network List of Renee Lentini

No Data

Ownership Network Relation of Renee Lentini


Renee Lentini Owned Company Details

What does Immunogen Inc do?

Who are the key executives at Immunogen Inc?

Renee Lentini is the V.P.-Fin. & Prin. Acctg. Off. of Immunogen Inc. Other key executives at Immunogen Inc include director & Chief Executive Officer Mark J Enyedy , Chief Business Officer Stacy Ann Coen , and VP of Regulatory Affairs Theresa Wingrove .

Immunogen Inc (IMGN) Insider Trades Summary

Over the past 18 months, Renee Lentini made 4 insider transaction in Immunogen Inc (IMGN) with a net sale of 377,001. Other recent insider transactions involving Immunogen Inc (IMGN) include a net sale of 1,058,614 shares made by Theresa Wingrove , a net sale of 301,809 shares made by Stacy Ann Coen , and a net sale of 3,027,661 shares made by Mark J Enyedy .

In summary, during the past 3 months, insiders sold 0 shares of Immunogen Inc (IMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,785,085 shares of Immunogen Inc (IMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,785,085 shares.

Immunogen Inc (IMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunogen Inc Insider Transactions

No Available Data

Renee Lentini Mailing Address

Above is the net worth, insider trading, and ownership report for Renee Lentini. You might contact Renee Lentini via mailing address: 830 Winter Street, Waltham Ma 02451.

Discussions on Renee Lentini

No discussions yet.